Drs. Heidi Nelson and Karen Oh discuss when women should get mammograms.

A study led by researchers at Casey Eye Institute finds ophthalmologists spend more than a quarter of their time with patients on electronic health records, despite already having limited time overall to spend with patients.

Dr. Vinay Prasad says about 36 percent of patients who go into remission with a newly approved treatment for leukemia will relapse in one year, calls for drug maker to issue refunds to patients who relapse within three years.

Kristin Knight discusses the long-term outcomes of ototoxicity in families with children who underwent cisplatin therapy for pediatric cancer and are developing hearing loss.”

OPB-Radio interviews Knight Cancer Institute leaders for a series of stories on the new research building, early cancer detection.

School of Medicine's Your M.D. curriculum is among Modern Healthcare magazine’s "leadership tools that prepare med students for the new world."

OPB-Radio interviews Knight Cancer Institute leaders for a series of stories on the new research building, early cancer detection.

In response to a study that found most new cancer drugs approved in Europe in recent years can’t help patients live longer or improve their quality of life, Dr. Vinay Prasad says: “While it makes sense to use drugs that shrink cancer and slow growth, the reality is sometimes we do that, but a person doesn’t live any longer.

Data presented by Dr. Stephen Heitner at the Heart Failure Society of American Annual Scientific Meeting show the drug Mavacamten improved left ventricular outflow and other metrics in patients with symptomatic obstructive hypertrophic cardiomyopathy.

In response to an individual who encourages patients to create do-it-yourself medicines, Dr. Vinay Prasad says, “He’s another symptom of the disease, and the disease is drug pricing.”